Phoreus Biotechnology, Inc. was founded with the mission to revolutionize global One Health through its proprietary peptide nanocarrier technology. The company focuses on precision drug delivery, particularly for the next generation of genetic vaccines and therapeutics. Phoreus offers two main technology platforms: Branched Amphipathic Peptide Capsules®️ (BAPC®️) and Corralling Amphipathic Peptide Colloids™️️ (CAPC™️️), which significantly enhance the efficacy of targeted, precision delivery systems.
Notable affiliated individuals and investors have not been disclosed publicly. However, Phoreus Biotechnology has achieved significant milestones in developing its proprietary platforms, positioning itself as a leader in the field of precision drug delivery. The impact of their technology promises to advance genetic technology and improve global health outcomes by providing more effective and targeted therapeutic solutions.
